Forget Gilead Sciences: These Stocks Doubled Last Year
Interested in stocks with huge growth potential? These three stocks hold promise for big gains in the years ahead.
International Growth Propels Gilead Sciences Inc.'s Solid Q4 Results
The big biotech overcame a tough U.S. environment for its hepatitis C drugs to succeed in the fourth quarter.